RNA Disease Diagnostics, Inc., a company developing a best-in-class molecular diagnostics platform to democratize point-of-care and home-use infectious disease detection, announced the appointments of its Chief Scientific Advisor, Professor Dipanjan Pan, M.S., Ph.D., and its President, John W. Erickson, Jr., to the Company’s Board of Directors.
April 4, 2022
· 4 min read